Assignee profile:

STATENS SERUM INSTITUT

City:

Copenhagen

Country:

Denmark

Published Applications:

18

Last publication date:

2024-12-05

Patent Grants:

17

Last grant date:

2026-04-21

Top Inventors for applications by STATENS SERUM INSTITUT

These are the the leading inventors for applications assigned to STATENS SERUM INSTITUT:

Recent patent applications by STATENS SERUM INSTITUT

STATENS SERUM INSTITUT based in Copenhagen, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-05 ✅ Patent 12,605,434 granted on 2026-04-21
US20240398916A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES

#2 | 2023-09-21
US20230298758A1
Physics

Systems and Methods for Evaluating Gestational Progress and Applications Thereof

#3 | 2019-04-04 ✅ Patent 10,925,954 granted on 2021-02-23
US20190099478A1
Human necessities

Vaccines against sp

#4 | 2017-08-31 ✅ Patent 10,729,765 granted on 2020-08-04
US20170246295A1
Human necessities

Alpha-tocopherol-based adjuvanted solvent for DNA vaccines

#5 | 2017-01-19 ✅ Patent 10,641,770 granted on 2020-05-05
US20170016897A1
Physics

Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis

#6 | 2015-10-15 ✅ Patent 9,410,960 granted on 2016-08-09
US20150293111A1
Physics

Method of diagnosing galactosemia in neonatal screening

#7 | 2011-09-22 ✅ Patent 9,764,024 granted on 2017-09-19
US20110229518A1
Human necessities

Optimized influenza vaccines

#8 | 2011-08-25 ✅ Patent 8,101,193 granted on 2012-01-24
US20110206713A1
Chemistry; metallurgy

Tuberculosis vaccines comprising antigens expressed during the latent infection phase

#9 | 2010-07-29 ✅ Patent 8,114,609 granted on 2012-02-14
US20100190174A1
Physics

ADAM12, a novel marker for abnormal cell function

#10 | 2010-06-24 ✅ Patent 8,288,090 granted on 2012-10-16
US20100160421A1
Human necessities

Influenza vaccines

#11 | 2009-12-10 ✅ Patent 8,889,142 granted on 2014-11-18
US20090304722A1
Chemistry; metallurgy

antigens for vaccine and diagnostic use

#12 | 2008-10-30 ✅ Patent 8,076,469 granted on 2011-12-13
US20080267990A1
Chemistry; metallurgy

TB diagnostic based on antigens from

#13 | 2008-06-26 ✅ Patent 9,140,691 granted on 2015-09-22
US20080153116A1
Physics

Diagnostic blood test using adsorption on filter paper

#14 | 2008-04-17 ✅ Patent 7,776,821 granted on 2010-08-17
US20080090761A1
Performing operations; transporting

Method comprising nanofiltration to obtain an MBL product safe from infectious agents and the product obtainable by this method

#15 | 2006-11-21 ✅ Patent 7,138,120 granted on 2006-11-21
US9902174
-

Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

#16 | 2006-06-22 ✅ Patent 7,678,544 granted on 2010-03-16
US20060134654A1
Physics

ADAM12, a novel marker for abnormal cell function

#17 | 2006-01-03 ✅ Patent 6,982,085 granted on 2006-01-03
US10138473
-

TB diagnostic based on antigens from M. tuberculosis

#18 | 2005-01-27 ✅ Patent 6,921,808 granted on 2005-07-26
US20050020816A1
Human necessities

Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal product

Also check out Statens Serum Institut's (Copenhagen, Denmark) applicant profile with 4 patent applications submitted.

AssigneeID:

205093 ⎘